BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30545016)

  • 1. Comparison of Clinical Manifestations, Antimicrobial Susceptibility Patterns, and Mutations of Fluoroquinolone Target Genes between Elizabethkingia meningoseptica and Elizabethkingia anophelis Isolated in Taiwan.
    Lin JN; Lai CH; Yang CH; Huang YH
    J Clin Med; 2018 Dec; 7(12):. PubMed ID: 30545016
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical manifestations, molecular characteristics, antimicrobial susceptibility patterns and contributions of target gene mutation to fluoroquinolone resistance in Elizabethkingia anophelis.
    Lin JN; Lai CH; Yang CH; Huang YH; Lin HH
    J Antimicrob Chemother; 2018 Sep; 73(9):2497-2502. PubMed ID: 29846598
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Lin JN; Lai CH; Yang CH; Huang YH
    Microorganisms; 2019 Aug; 7(9):. PubMed ID: 31466280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative Prevalence and Antimicrobial Susceptibility of Clinical Isolates of Elizabethkingia Species Based on 16S rRNA Gene Sequencing.
    Han MS; Kim H; Lee Y; Kim M; Ku NS; Choi JY; Yong D; Jeong SH; Lee K; Chong Y
    J Clin Microbiol; 2017 Jan; 55(1):274-280. PubMed ID: 27847376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial Susceptibility of
    Comba IY; Schuetz AN; Misra A; Friedman DZP; Stevens R; Patel R; Lancaster ZD; Shah A
    J Clin Microbiol; 2022 Jun; 60(6):e0254121. PubMed ID: 35510517
    [No Abstract]   [Full Text] [Related]  

  • 6. Investigation of Phylogeny and Drug Resistance Mechanisms of
    Larkin PMK; Mortimer L; Malenfant JH; Gaynor P; Contreras DA; Garner OB; Yang S; Allyn P
    Microb Drug Resist; 2021 Sep; 27(9):1259-1264. PubMed ID: 33656389
    [No Abstract]   [Full Text] [Related]  

  • 7. Susceptibility of Elizabethkingia spp. to commonly tested and novel antibiotics and concordance between broth microdilution and automated testing methods.
    Kuo SC; Tan MC; Huang WC; Wu HC; Chen FJ; Liao YC; Wang HY; Shiau YR; Lauderdale TL
    J Antimicrob Chemother; 2021 Feb; 76(3):653-658. PubMed ID: 33258923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre study evaluating matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically isolated Elizabethkingia species and analysis of antimicrobial susceptibility.
    Cheng YH; Perng CL; Jian MJ; Cheng YH; Lee SY; Sun JR; Shang HS
    Clin Microbiol Infect; 2019 Mar; 25(3):340-345. PubMed ID: 29689427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Evolutionary Trend and Genomic Features of an Emerging Lineage of Elizabethkingia anophelis Strains in Taiwan.
    Lee YL; Liu KM; Chang HL; Liao YC; Lin JS; Kung FY; Ho CM; Lin KH; Chen YT
    Microbiol Spectr; 2022 Feb; 10(1):e0168221. PubMed ID: 35044198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Characteristics and Antimicrobial Susceptibility Profiles of
    Wang L; Zhang X; Li D; Hu F; Wang M; Guo Q; Yang F
    Infect Drug Resist; 2020; 13():247-256. PubMed ID: 32099417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elizabethkingia anophelis bacteremia is associated with clinically significant infections and high mortality.
    Lau SK; Chow WN; Foo CH; Curreem SO; Lo GC; Teng JL; Chen JH; Ng RH; Wu AK; Cheung IY; Chau SK; Lung DC; Lee RA; Tse CW; Fung KS; Que TL; Woo PC
    Sci Rep; 2016 May; 6():26045. PubMed ID: 27185741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular typing and profiling of topoisomerase mutations causing resistance to ciprofloxacin and levofloxacin in
    Jian MJ; Cheng YH; Perng CL; Shang HS
    PeerJ; 2018; 6():e5608. PubMed ID: 30225179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the therapeutic efficacy of fluoroquinolone and non-fluoroquinolone treatment in patients with Elizabethkingia meningoseptica bacteraemia.
    Huang YC; Lin YT; Wang FD
    Int J Antimicrob Agents; 2018 Jan; 51(1):47-51. PubMed ID: 28668676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Jiun-Nong Lin; Chung-Hsu Lai; Chih-Hui Yang and Yi-Han Huang. Comparison of Clinical Manifestations, Antimicrobial Susceptibility Patterns, and Mutations of Fluoroquinolone Target Genes between
    Lin JN; Lai CH; Yang CH; Huang YH
    J Clin Med; 2019 Apr; 8(4):. PubMed ID: 31013674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone resistance in carbapenem-resistant Elizabethkingia anophelis: phenotypic and genotypic characteristics of clinical isolates with topoisomerase mutations and comparative genomic analysis.
    Jian MJ; Cheng YH; Chung HY; Cheng YH; Yang HY; Hsu CS; Perng CL; Shang HS
    J Antimicrob Chemother; 2019 Jun; 74(6):1503-1510. PubMed ID: 30830171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic Combination to Effectively Postpone or Inhibit the In Vitro Induction and Selection of Levofloxacin-Resistant Mutants in
    Lee CC; Lai CH; Yang CH; Huang YH; Lin JN
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Strains of Chryseobacterium and Elizabethkingia spp. Isolated from Pediatric Patients in a University Hospital: Performance of MALDI-TOF MS-Based Identification, Antimicrobial Susceptibilities, and Baseline Patient Characteristics.
    Mirza HC; Tuncer Ö; Ölmez S; Şener B; Tuğcu GD; Özçelik U; Gürsoy NC; Otlu B; Büyükçam A; Kara A; Sancak B
    Microb Drug Resist; 2018; 24(6):816-821. PubMed ID: 29227188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Elizabethkingia spp. infections in a university hospital: coinfection with SARS-CoV-2 and first report of Elizabethkingia anophelis in Chile].
    Reyes-Barros T; Uribe-Monasterio J; Gándara-Fuenzalida V; Pinochet-Valenzuela F; Yáñez-Ferrada T; García-Cañete P; Castillo-Vega C; Lam-Esquenazi M; Pizarro-Henríquez E; Corsi-Soteo Ó
    Rev Chilena Infectol; 2021 Oct; 38(5):613-621. PubMed ID: 35506827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biofilm formation and antibiotic sensitivity in
    Hu S; Lv Y; Xu H; Zheng B; Xiao Y
    Front Cell Infect Microbiol; 2022; 12():953780. PubMed ID: 35967866
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences in Clinical Manifestations, Antimicrobial Susceptibility Patterns, and Mutations of Fluoroquinolone Target Genes between Chryseobacterium gleum and Chryseobacterium indologenes.
    Lin JN; Lai CH; Yang CH; Huang YH
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.